zh-twzhen
zh-twzhen

News

2023

Date

Title

2023-12-25

Oneness has submitted medical device registration application of Bonvadis for wound care to the Saudi Food and Drug Authority (SFDA) in Kingdom of Saudi Arabia.

>
2023-12-19

Oneness announces the information about the investor’s conference of 2023 Q4.

>
2023-12-13

Oneness Biotech Co., Ltd. receives an Indian patent titled “TOPICAL FORMULATION FOR PROMOTING WOUND HEALING” on Fespixon cream (Research code: ON101).

>
2023-12-09

News-Oneness is the first pharmaceutical company in Taiwan has been selected for inclusion in the Dow Jones Sustainability Index

>
2023-12-07

Oneness Biotech Co., Ltd. receives a Brazilian patent titled “TOPICAL FORMULATION FOR PROMOTING WOUND HEALING” on Fespixon cream (Research code: ON101).

>
2023-12-05

A U.S. patent titled ”METHODS FOR PREPARATION OF PLECTRANTHUS AMBOINICUS EXTRACTS” has been granted.

>
2023-12-04

Oneness Biotech Co., Ltd. receives a Japanese patent titled “TREATING IGE-MEDIATED ALLERGIC DISEASES” on FB825.

>
2023-11-30

Oneness announces the resolution of the Board of Directors on the Record Date of Capital Increase for the issuance of Restricted Employee Shares in 2023.

>
2023-11-29

An European patent titled “USE OF FLAVONOID COMPOUND IN PREPARATION OF COMPOSITION FOR HEALING WOUND” has been granted.

>
2023-11-13

News-Taiwan’s First Category 1.1 Natural Drug Approved for Market in China

>
2023-11-10

Oneness Biotech Co., Ltd. receives a Hong Kong patent titled “TOPICAL FORMULATION FOR PROMOTING WOUND HEALING” on Fespixon cream (Research code: ON101).

>
2023-11-09

FESPIXON, the new drug in treatment of diabetic foot ulcers has been approved as Class 1.1 natural new drug by National Medical Products Administration (NMPA) in China

>
2023-11-09

The Company’s 2023Q3 consolidated financial statements have been approved by the Board of Directors

>
2023-10-25

Oneness has submitted medical device registration application of Bonvadis for wound care to the Thai Food and Drug Administration (Thai FDA) in Thailand.

>
2023-10-04

The board of directors of the Company approved removal of the noncompete clause for managers.

>